Aurora Cannabis Inc.
NASDAQ Global SelectCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Miguel Martin
- Full Time Employees
- 1,028
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Address
- 500 - 10355 Jasper Avenue Edmonton AB Canada T6X1V8
- IPO Date
- Jul 15, 2014
- CIK
- 0001683541
- Website
- auroramj.com
- Similar Companies
- Business
- Aurora Cannabis Inc. produces and distributes medical and consumer cannabis products worldwide from its headquarters in Edmonton, Alberta, Canada, where the company was founded in 2006. The company offers pharmaceutical-grade cannabis including dried flower, oils, extracts, capsules, pre-rolls, vapes, edibles, concentrates, and topicals under brands such as Drift, San Rafael '71, Daily Special, Tasty's, MedReleaf, CraftPlant, Farm Gas, and Sourdough; it also provides patient counseling, outreach services, and plant propagation through its controlling interest in Bevo Farms Ltd., with operations spanning Canada, Europe (including Germany, Poland, and Denmark), Australia, Latin America, and other international markets. Aurora Cannabis operates through Canadian cannabis and plant propagation segments, focusing on GMP-certified production for medical patients and premium adult-use consumers while leveraging advanced cultivation facilities and a hybrid manufacturing network that incorporates third-party supply. In recent developments, Aurora Cannabis expanded its partnerships with a three-year $27 million supply agreement with SNDL Inc. for premium flower from New Brunswick, strengthening its hybrid manufacturing strategy following record growth in international medical cannabis; the company launched its first German-grown products with Demecan and highest-THC medical offerings in Poland, including Farm Gas (27% THC) and Sourdough (29% THC); it announced a distribution partnership with Leafio Australia to broaden access for brands like MedReleaf and CraftPlant after acquiring MedReleaf Australia in February 2024; and introduced innovative medical cannabis-infused ready-to-drink beverages like VACAY's Strawberry Pineapple Tropical Soda for veteran patients.
ACB Stock Down 28% in Three Months: Time to Buy the Dip or Cash Out?
Aurora Named to TIME Canada's Best Companies 2026 List
Aurora Cannabis Inc. Announces Filing and Mailing of the Management Information Circular in Connection with the Annual General Meeting of Shareholders
Aurora Q4 Earnings Call Flags Reset Year as Canada Pressure Weighs
Aurora Cannabis: Weak Near-Term Outlook But Too Cheap To Ignore - Buy
Aurora Cannabis Q4 Earnings Call Highlights
Aurora Cannabis Announces Full Year and Fiscal 2026 Fourth Quarter Results with Record Annual Revenue and Adjusted EBITDA¹
Wall Street Week Ahead
Aurora Deepens its Impact for Veterans Across Canada
Aurora Cannabis to Host Fourth Quarter and Fiscal Year 2026 Investor Conference Call and File Related Year End Information
Top Canadian Marijuana Stock Choices For Better Investing In 2026
Aurora Granted Plant Breeders' Rights, Strengthening Leadership in Cannabis Science
Aurora Advances Global Medical Cannabis Portfolio with New Product Launches Across Key International Markets
Aurora Cannabis: Why I Like This Stock
Finally. Marijuana Gets Reclassified, but Are Pot Stocks Still Too Risky?
Aurora Cannabis Accelerates Global Medical Cannabis Leadership with Accretive Acquisition of Safari Flower Company, Expanding EU GMP Capacity to Serve Growing High Margin International Markets
Cannabis Stock ACB Down 19% YTD: Should You Buy the Dip?
3 Canadian Cannabis Stocks Ready for Potential Breakouts in April 2026
Aurora Recognized for Executive Gender Diversity by the Globe & Mail for Second Consecutive Year
Top Canadian Marijuana Stocks To Watch This Month For Better Trading